BeOne Medicines AG
ONC
$335.17
$2.460.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 109.75% | 67.35% | 50.47% | 26.85% | 15.14% |
| Total Depreciation and Amortization | 30.89% | 228.93% | 230.42% | 240.77% | 1,092.38% |
| Total Amortization of Deferred Charges | 81.03% | 188.61% | 101.06% | 122.04% | 847.58% |
| Total Other Non-Cash Items | 15.04% | 1,398.57% | 2,138.84% | 4,978.69% | 604.78% |
| Change in Net Operating Assets | 74.49% | 67.68% | 4.91% | 19.73% | -22,747.50% |
| Cash from Operations | 234.40% | 189.15% | 128.24% | 90.82% | 42.18% |
| Capital Expenditure | 55.06% | 43.61% | 33.36% | 11.43% | 3.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.92% | -2,381.92% | -225.53% | -135.67% | -127.50% |
| Cash from Investing | 38.81% | 1.83% | -52.96% | -1,522.37% | -286.11% |
| Total Debt Issued | -7.65% | -8.31% | -2.89% | 28.95% | 149.95% |
| Total Debt Repaid | -159.49% | 17.48% | -2.74% | 21.18% | 68.54% |
| Issuance of Common Stock | 379.47% | -23.20% | -40.59% | -75.73% | -78.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 6.81% | 6.81% | 6.81% | 6.81% |
| Other Financing Activities | 4,149.53% | 120.41% | 122.55% | 122.55% | 116.41% |
| Cash from Financing | 71.40% | -90.31% | -94.65% | -45.01% | 853.56% |
| Foreign Exchange rate Adjustments | 7.98% | -63.85% | 42.13% | -538.00% | -120.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 256.77% | 110.99% | 50.73% | 7.47% | -31.71% |